IDT Launches Synthetic Biology Custom Solutions Team and Improves Gene Fragment Offerings with Next-Day Shipping and Transparent Pricing
PorAinvest
jueves, 10 de julio de 2025, 3:38 pm ET1 min de lectura
DHR--
Ajay Gannerkote, President of IDT, stated, "Our mission has always been to empower scientists to develop solutions that matter to customers and move faster without compromising quality. We were the first to bring gBlocks Gene Fragments to the market, and we’ve never stopped innovating. Today, we continue to invest in our platforms and infrastructure to push turnaround times even further—because accelerating discovery is what we do best" [1].
The new eBlocks Gene Fragments and SynBio Custom Solutions are compatible with major cloning techniques and are designed for higher yields and fewer reorders. These improvements are part of IDT's ongoing commitment to innovation and reliability, which has been trusted by leading academic institutions and biotech innovators worldwide [1].
Twist Bioscience Corporation (TWST), a key player in the life sciences segment, has also accelerated its turnaround time for gene fragments to just two business days, with pricing starting at seven cents per base pair [2]. This move underscores the growing competition in the synthetic biology market, where both IDT and Twist are focusing on speed, precision, and affordability to meet the needs of researchers in various fields.
IDT's new synthetic biology custom solutions team offers tailor-made solutions, including codon optimization, vector selection, and expression tuning, ensuring each construct is designed around the researcher's goals rather than vendor limitations. This personalized approach positions IDT as a pivotal partner for researchers aiming for precision and efficiency in their scientific endeavors [1].
The company's strategic focus on innovation and customer satisfaction is evident in its commitment to continuous improvement. IDT's Danaher Business System (DBS) and new investments have enabled these enhancements, positioning the company as a leader in the genomics industry [1].
References:
[1] https://www.businesswire.com/news/home/20250710425195/en/IDT-Launches-All-Inclusive-Gene-Fragments-From-7-Cents-Per-Base-With-25-Lower-Turnaround-Times-and-Next-Day-Shipping-Powered-by-Its-Cutting-Edge-Synthetic-Biology-Facility
[2] https://www.gurufocus.com/news/2961054/twist-bioscience-expands-express-delivery-turnaround-time-to-all-gene-fragments-regardless-of-format-twst-stock-news
TWST--
IDT has launched all-inclusive gene fragments from $0.07 per base with 25% lower turnaround times and next-day shipping. The company has expanded its offerings via a new synthetic biology custom solutions team and improved manufacturing capabilities. IDT's new eBlocks Gene Fragments and SynBio Custom Solutions aim to help scientists move from idea to experiment faster with customizable solutions tailored to any research challenge.
Integrated DNA Technologies (IDT) has expanded its gene fragment offerings with a new synthetic biology custom solutions team and improved manufacturing capabilities. The company has announced the launch of all-inclusive gene fragments at $0.07 per base pair, a 25% reduction in turnaround times, and next-day shipping. These enhancements are designed to help scientists move from idea to experiment faster with customizable solutions tailored to any research challenge [1].Ajay Gannerkote, President of IDT, stated, "Our mission has always been to empower scientists to develop solutions that matter to customers and move faster without compromising quality. We were the first to bring gBlocks Gene Fragments to the market, and we’ve never stopped innovating. Today, we continue to invest in our platforms and infrastructure to push turnaround times even further—because accelerating discovery is what we do best" [1].
The new eBlocks Gene Fragments and SynBio Custom Solutions are compatible with major cloning techniques and are designed for higher yields and fewer reorders. These improvements are part of IDT's ongoing commitment to innovation and reliability, which has been trusted by leading academic institutions and biotech innovators worldwide [1].
Twist Bioscience Corporation (TWST), a key player in the life sciences segment, has also accelerated its turnaround time for gene fragments to just two business days, with pricing starting at seven cents per base pair [2]. This move underscores the growing competition in the synthetic biology market, where both IDT and Twist are focusing on speed, precision, and affordability to meet the needs of researchers in various fields.
IDT's new synthetic biology custom solutions team offers tailor-made solutions, including codon optimization, vector selection, and expression tuning, ensuring each construct is designed around the researcher's goals rather than vendor limitations. This personalized approach positions IDT as a pivotal partner for researchers aiming for precision and efficiency in their scientific endeavors [1].
The company's strategic focus on innovation and customer satisfaction is evident in its commitment to continuous improvement. IDT's Danaher Business System (DBS) and new investments have enabled these enhancements, positioning the company as a leader in the genomics industry [1].
References:
[1] https://www.businesswire.com/news/home/20250710425195/en/IDT-Launches-All-Inclusive-Gene-Fragments-From-7-Cents-Per-Base-With-25-Lower-Turnaround-Times-and-Next-Day-Shipping-Powered-by-Its-Cutting-Edge-Synthetic-Biology-Facility
[2] https://www.gurufocus.com/news/2961054/twist-bioscience-expands-express-delivery-turnaround-time-to-all-gene-fragments-regardless-of-format-twst-stock-news

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios